With regard to the relationship between exogenous insulin and adiponectin in vivo, there is one study in pediatric type 1 diabetes reporting an increase in adiponectin 1 month after initiation of insulin therapy [19], while, to date, there is no published study in type 2 diabetes. This evidence concerns the gene ADIPOQ and type 1 diabetes mellitus.